Compare ELS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELS | ICLR |
|---|---|---|
| Founded | 1992 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 13.1B |
| IPO Year | 1994 | 2001 |
| Metric | ELS | ICLR |
|---|---|---|
| Price | $61.10 | $195.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 18 |
| Target Price | $68.26 | ★ $231.29 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 10-20-2026 | 10-27-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ 2.55 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $1,531,382,000.00 | N/A |
| Revenue This Year | $2.50 | N/A |
| Revenue Next Year | $4.47 | $4.60 |
| P/E Ratio | $40.66 | ★ $12.91 |
| Revenue Growth | ★ 0.34 | N/A |
| 52 Week Low | $57.46 | $66.57 |
| 52 Week High | $69.00 | $219.04 |
| Indicator | ELS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 51.53 |
| Support Level | $61.11 | $157.92 |
| Resistance Level | $63.67 | $219.04 |
| Average True Range (ATR) | 1.15 | 7.11 |
| MACD | -0.03 | -2.33 |
| Stochastic Oscillator | 48.47 | 21.43 |
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company has a portfolio of 453 properties across the US with a higher concentration in the Sun Belt; 38% of its properties are in Florida, 11% in Arizona, and 10% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.